Literature DB >> 6377906

Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.

U H Rudofsky, R L Dilwith, J B Roths, D A Lawrence, V E Kelley, A M Magro.   

Abstract

Lupus-prone (NZB X NZW)F1 (B X W) mice and MRL-lpr and BXSB mice were examined for the prevalence of hypertension and levels of plasma renin activity (PRA). Hypertension (greater than 145 mmHg) was observed only in female and male B X W mice with severe nephritis; in female MRL-lpr and male BXSB mice severe nephritis developed without blood pressure elevation (80-135 mmHg). The B X W parental strains, NZB and NZW, and the MRL-lpr congenic partners, MRL- +, did not become hypertensive as they aged. Other strains of mice, aged 3-32 months (A/HeN, BALB/cJ, BALB/cByJ, B10.S/Sg, B10.D2/ oSn , CBA/J, C3H/HeJ, SJL/J and [SJL X NZW]F1), also had normal blood pressure (98-122 mmHg). All mice with lupus nephritis had low PRA, even those with hypertension; furthermore, the MRL-lpr strain had low or undetectable PRA (2 +/- 1 ng/ml/hr), even when kidneys were normal. NZB, NZW, and MRL- + mice had normal PRA (10-16 ng/ml/hr). Thus, B X W mice frequently developed low renin hypertension during the last phase of their renal disease; whereas MRL-lpr and BXSB mice died from renal disease without observable increases in blood pressure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377906      PMCID: PMC1900373     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Unilateral nephrectomy: effect on survival in NZB/NZW mice.

Authors:  M M Beyer; A D Steinberg; A D Nicastri; E A Friedman
Journal:  Science       Date:  1977-11-04       Impact factor: 47.728

2.  Prolonged survival of hypertransfused NZB/NZW mice.

Authors:  A E Gabrielsen; C T Olsen
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

Review 3.  The immunology and pathology of NZB mice.

Authors:  J B Howie; B J Helyer
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

4.  Plasma renin activity in psychosocial hypertension of CBA mice.

Authors:  A J Vander; J P Henry; P M Stephens; L L Kay; D R Mouw
Journal:  Circ Res       Date:  1978-04       Impact factor: 17.367

5.  Immune complexes in skin of NZB/NZW mice.

Authors:  V M Sommer; U H Rudofsky; A E Gabrielsen
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

6.  Subepidermal deposition of immunoglobulin in NZB/NZW F hybrid mice.

Authors:  J N Gilliam; E R Hurd; M Ziff
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

7.  Dactinomycin treatment of murine lupus erythematosus. I. Renal disease and longevity.

Authors:  U H Rudofsky; R E Urizar; A E Gabrielsen; A D Simmons; C T Olsen
Journal:  Lab Invest       Date:  1978-11       Impact factor: 5.662

8.  Influence of diet on survival of mice.

Authors:  G Fernandes; E J Yunis; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

9.  Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice.

Authors:  J R Roubinian; N Talal; J S Greenspan; J R Goodman; P K Siiteri
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  19 in total

1.  Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.

Authors:  Keisa W Mathis; Erin B Taylor; Michael J Ryan
Journal:  Pharmacol Res       Date:  2017-04-08       Impact factor: 7.658

2.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.

Authors:  Tang-Dong Liao; Pablo Nakagawa; Branislava Janic; Martin D'Ambrosio; Morel E Worou; Edward L Peterson; Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-04

Review 3.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

4.  Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosus.

Authors:  Marcia Venegas-Pont; Keisa W Mathis; Radu Iliescu; William H Ray; Porter H Glover; Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-07       Impact factor: 3.619

Review 5.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

6.  Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.

Authors:  Erin B Taylor; Michelle T Barati; David W Powell; Hannah R Turbeville; Michael J Ryan
Journal:  Hypertension       Date:  2018-01-29       Impact factor: 10.190

7.  Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome.

Authors:  A Kolyada; Q Ke; I Karageorgos; P Mahlawat; D A Barrios; P M Kang; N Beglova
Journal:  J Thromb Haemost       Date:  2016-05-03       Impact factor: 5.824

8.  Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus.

Authors:  Elena L Dent; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09

9.  Hypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves.

Authors:  Keisa W Mathis; Marcia Venegas-Pont; Elizabeth R Flynn; Jan Michael Williams; Christine Maric-Bilkan; Terry M Dwyer; Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-08-07       Impact factor: 3.619

10.  High frequency of nocturnal hypertension in lupus nephritis: should ABPM be implemented in usual practice?

Authors:  Juan M Mejia-Vilet; Yesser J López-Hernández; Mariedel Trujeque-Matos; J Iván Santander-Velez; Mayra L Cano-Verduzco; Cristino Cruz; Luis E Morales-Buenrostro
Journal:  Clin Rheumatol       Date:  2019-12-14       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.